Roche’s Phase III TIGIT Failure In Metastatic SCLC Disappoints But Is Small Loss

 
• By Ayisha Sharma
open road in desert
The Road To Success Is Clear For Tiragolumab Despite A Short-Term Setback • Source: Alamy

More from Clinical Trials

More from R&D